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 1. Introduction 
Early repolarization (ER) patterns in electrocardiogram (ECG), often 
characterized by a “notch” or “slur” at the J point, have gained increasing attention 
because of its association with recurrent ventricular fibrillation (1). Although ER pattern 
in ECG has been considered as a benign manifestation commonly seen in healthy young 
males or athletes, several lines of evidence have suggested ER patterns sporadically 
predict lethal ventricular arrhythmias associated with J wave syndrome (JWS) including 
ER syndrome (ERS) and Brugada syndrome (BrS) (2). 
Emerging evidence indicates that the pathogenesis of JWS partly associates with 
a genetic variant of KCNJ8 (Kir6.1) gene, encoding a pore-forming subunit of ATP-
sensitive potassium (KATP) channel (3). A missense mutation of serine at position 422 in 
Kir6.1 to leucine (S422L) has been disclosed in association with ERS (4). Heterologous 
expression of Kir6.1 and SUR2A in cultured cells extrapolated that S422L mutation can 
augment KATP channel activity due to the reduced sensitivity to intracellular ATP (5,6). 
Thus, the causal link between JWS and the gain-of-function mutation (S422L) in Kir6.1 
has been proposed.  
The KATP channel was identified in cardiomyocytes as a regulator of cellular 
energy metabolism in the control of membrane excitability (7). The KATP channel is a 
hetero-octameric protein of four pore-forming Kir6.x and four sulfonylurea receptor 
(SUR) subunits (7). The sarcolemmal KATP channels in ventricular myocytes are 
composed primarily of Kir6.2 and SUR2A subunits whereas KATP channels in vascular 
smooth muscle cells are composed primarily of Kir6.1 and SUR2B. Kir6.1 subunit plays 
a critical role in the regulation of vascular contractility (7); however, little is known about 
the physiological role of Kir6.1 in the KATP channel activities in cardiomyocytes. 
We hence focused on the Kir6.1 in cardiomyocytes to test the hypothesis whether 
the Kir6.1-S422L mutation can be a direct cause of JWS in vivo. We created Kir6.1 
transgenic (TG) mouse strains overexpressing S422L mutant (TGmt) or wild-type 
(TGWT) in cardiomyocytes, respectively, to investigate the potential impact on the 
cardiac electrophysiology. Electrophysiological data, obtained from this study, did not 
support the hypothesis that Kir6.1-S422L mutation is a direct cause of JWS. 
 
2. Materials and Methods 
2.1. Kir6.1 transgenic mice 
 A fusion gene comprising promoter region of the mouse alpha myosin heavy 
chain gene (generous gift by Dr. J. Gulick) (8) and rat KCNJ8 (Kir6.1) cDNA coding 
sequences (9) was cloned into pBlueScriptII-SK(+) plasmid. The S422L mutation in 
KCNJ8 was introduced by PCR with the primer set, Kir6.1HumRat-S422L (Table 1) 
using PrimeSTAR HS DNA polymerase (Takara Bio, Shiga). Since the S422L mutation 
was identified from the human subjects and closely locates to the C-terminal, two 
additional mutations (C420N and P421T) were introduced to humanize the surrounding 
amino acids, resulting in the amino acid sequence (396–424) identical to human 
KCNJ8. This construct was termed as the humanized S422L mutant. Plasmids for 
KCNJ8 wild-type and humanized S422L mutant were confirmed by DNA sequencing. 
The alpha-MHC-Kir6.1 cassette was micro-injected into the pronucleus of fertilized 
C57BL/6NCrSlc mice (SLC, Shizuoka) eggs. Transgenic (TG) mice were identified by 
PCR of tail DNA with the primer set, aMHC-1fw and Kir6.1-3rc. At least two lines of 
transgenic mouse strains for each KCNJ8 transgene were selected for the experiments.  
Transgenic mice were used as heterozygotes, and bred at the animal facility of 
Chiba University. Animals were maintained on standard mouse food on a 12-h light/12-
h dark cycle.  All experimental procedures were approved by the animal research 
committee of Chiba University. All data were obtained from 10 to 20-wk-old male and 
female TG mice and age-matched non-transgenic C57BL/6 mice were used as control 
mice. 
2.2. Gene expression analysis in the heart                                                                                                                                       
 Gene expression levels were analyzed by semi-quantitative real-time PCR. 
Mouse heart was quickly removed after sacrifice, stored in RNAlater Stabilization 
Solution (Ambion, Austin, TX, USA) at −80 ºC until use. Ventricular tissue was 
sampled in RNAlater under the stereomicroscope, and total RNA was extracted with 
RNAiso PLUS (Takara Bio, Shiga). Two μg of total RNA was then used to synthesize 
first strand cDNA with a SuperScript VILO cDNA Synthesis Kit (Invitrogen, Carlsbad, 
CA, USA). mRNA levels were quantified by real-time PCR with SYBR green dye 
(Toyobo, Osaka) with the specific primer sets shown in Table 1, and normalized to 
ribosomal protein L4 (RPL4) mRNA (10). Gene expression levels of KCNJ8 in 
ventricular tissues from TG mouse strains were in the range of 230–430-fold higher 
than those from WT littermates (data not shown). 
2.3. Surface ECG recordings and blood pressure measurements                                                     
 Mouse was anesthetized with a combination of midazolam (Astellas Pharma, 
Tokyo, 4 mg/kg), butorphanol (Meiji Seika Pharma, Tokyo, 5 mg/kg), and 
medetomidine (Nippon Zenyaku Kogyo, Fukushima, 0.3 mg/kg). Surface ECG 
recordings were performed on the temperature-controlled table. Since the diagnostic J-
wave of the human appears on a precordial lead (2), we recorded a precordial lead at the 
left anterior axillary line (V5) along with standard limb leads and analyzed V5 lead 
ECG. Noninvasive blood pressure (BP) measurement was performed by tail-cuff 
plethysmography (Softron Inc., Tokyo) in conscious mice.  
2.4. Isolation of ventricular cardiomyocytes                                                                         
 Anesthetized mouse was anticoagulated with heparin-Na (Mochida 
Pharmaceutical, Tokyo, 100 U/kg, i.v.). Heart was quickly excised and Langendorff-
perfused with oxygenated HEPES-Tyrode solution (pH 7.4) (11). The ventricular 
myocytes were enzymatically-isolated and stored in modified Kraft-Brühe solution.  
2.5. Patch-clamp experiments                                                                                                   
 The whole cell patch-clamp techniques were used for the electrical recordings 
of the action potential (AP), voltage-dependent K+ currents, and the pinacidil-induced 
KATP current at 37ºC.                                                                                                                                      
   Action potential was recorded in a current-clamp mode, and the voltage-
dependent K+ currents were recorded in a voltage-clamp mode. Whole cell currents 
were normalized as current density by cell capacitance. The pinacidil-induced KATP 
current was recorded in a voltage-clamp mode, using a ramp pulse protocol to obtain the 
quasi-steady-state membrane current. The pipette solution contains less ATP (1 mM, pH 
7.4). A patch-clamp amplifier (CEZ-2400, Nihon Kohden, Tokyo) was used and the 
current signals were digitized (Digidata 1322A, Axon Instruments Inc., Union City, CA, 
USA) at 2 kHz and stored on a computer for later analysis with pCLAMP9 software 
(Axon Instruments). 
Single KATP channel activity was recorded in the open cell-attached patches of 
the ventricular cells at room temperature, as previously described (12). The unitary KATP 
current was recorded as outward current with the glass pipette held inside at +40 mV. 
Single channel data were also analyzed with pCLAMP9 software. 
2.6. Materials and reagents 
 All materials were from Wako Pure Chemical Industries (Osaka) unless 
otherwise indicated. The following chemicals were purchased from Sigma-Aldrich (St. 
Louis, MO, USA); Pinacidil monohydrate (P154), glibenclamide (G0639), adenosine 
5’-triphosphate dipotassium salt (A8937), and EGTA (E4378). Creatine phosphate 
dipotassium salt (237911) was purchased from Calbiochem (La Jolla, CA, USA). 
2.7. Data Analysis                                                                                                                                 
 All data were expressed as mean ± SEM unless otherwise indicated. 
Statistical analysis of the data was performed with Prism software (Ver. 6, GraphPad 
Software, La Jolla, CA, USA) using one-way ANOVA with post-hoc Tukey HSD test. A 
p-value less than 0.05 was considered to be statistically significant. 
 
 
 
 
3. Results 
3.1. Creation of KCNJ8 (Kir6.1) transgenic mouse strains 
Following selection of founder mice in each transgene strain, founder mice were 
backcrossed to the parental C57BL/6 strain at least five generations to decrease the 
passenger gene effect (13) prior to the experimental use. We named TG strains expressing 
KCNJ8 wild-type gene as TGWT (Line 634, 673), and TG strains expressing KCNJ8 gene 
with humanized S422L mutation as TGmt (Line 105, 111). These TG mice grew normally 
and there were few unexpected sudden deaths observed until 20 weeks after birth. 
We referred the systemic blood pressure since vascular KATP channel is 
composed of Kir6.1 (7). There was no significant difference in blood pressure among 
WT and TG strains (WT: 106 ± 3 / 69 ± 2, TGmt: 100 ± 2 / 66 ± 2, and TGWT: 105 ± 2 
/ 69 ± 2 mmHg of systolic / diastolic blood pressure, 12–14 mice in each group). 
3.2. Atypical ECG changes in TG mice 
Electric activity of the heart was monitored by standard surface ECG recordings. 
In general, mouse ECG presents J point elevation as a notch followed by an inverted T 
wave, which is in analogous to human J wave pattern (Figure 1A WT) (14). The J point 
and the ST segment were the dominant targets among the Kir6.1 transgenic mice. Distinct 
patterns in the J-ST segment were characterized in two categories; one as enlarged J-wave 
and the other is J-ST segment depression (Figure 1A TGmt and TGWT). There were few 
observations in TG strains with normal ECG pattern similar to WT; however, ECG 
records from Line 673 (TGWT) were relatively similar to WT among TG strains.  
Further analyses of ECG records revealed that QT intervals from all TG strains, 
as well as QTc intervals, were significantly (about 60–100%) longer than WT (Figure 
1B). QT/QTc intervals from Line 673 (TGWT), whose ECG relatively resembled WT 
among the TG strains, were significantly shorter than other TG lines, although it was 
still 60% longer than WT.  
3.3. Membrane potentials recorded from ventricular myocytes 
 Since surface ECG recordings from TGmt and TGWT showed atypical 
patterns on the J-ST segment, we applied the patch-clamp techniques to reveal 
electrophysiological changes in a ventricular myocyte from these TG mice. Action 
potentials were recorded in a current-clamp mode (Figure 2A). APD at 90% 
repolarization level (APD90) was about 100–200% longer in TG ventricular cells than 
WT cells (Figure 2B). These findings are in line with the prolonged QT intervals 
recorded in surface ECG. However, there was no significant difference in APD90 
between TGmt and TGWT.  
3.4. Membrane currents in ventricular myocytes 
Since APD prolongation was remarkable in TG myocyte, we measured membrane 
currents. First in series, we focused on the voltage-dependent K+ currents such as the 
transient outward current (Ito), the delayed rectifier K+ current (IK), and the inward 
rectifier K+ current (IK1). Representative recordings of Ito and IK1 are shown in Figure 3A. 
It was obvious that ventricular cells from TG mouse had less Ito than WT ventricular cells. 
Figure 3B summarizes the Ito, IK, and IK1 densities normalized by membrane capacitance. 
Overall, TG myocytes had less K+ current densities compared with WT. Although there 
were no significant differences in Ito, IK, and IK1 densities among the ventricular cells of 
four TG lines, ventricular cells of Line 673 (TGWT) had comparatively large current 
densities especially in Ito and IK1.  
The L-type Ca2+ current was also measured. There were no significant differences 
in the peak Ca2+ current density between WT and both TG strains (data not shown). 
3.5. Pinacidil-induced KATP current in ventricular myocytes  
Pinacidil-induced KATP current was recorded using a ramp pulse protocol. 
Pinacidil at 100 μM successfully increased quasi-steady-state membrane current in 
ventricular cells from WT and TG mice. As shown in Figure 4A, the densities of 
pinacidil-induced outward current in ventricular cells from TG strains were smaller than 
that in WT ventricular cells. Glibenclamide clearly suppressed the pinacidil-induced 
KATP current in these cells. Figure 4B summarizes KATP current densities measured at 0 
mV following induction by pinacidil (100 μM). The KATP current density was 
significantly lower in TG ventricular cells about 40–60% compared with WT cells. 
There was no significant difference between TG strains (TGmt and TGWT). It was 
noticeable that pinacidil increased KATP current in TG cardiomyocyte less than WT cells 
(Figure 4C). Collectively, KATP channels in TG cardiomyocyte were less active than 
those in WT; furthermore, S422L variant of Kir6.1 (TGmt) did not increase KATP current 
compared with TGWT. 
3.6. Single KATP channel analysis 
We conducted single channel analysis in the open cell-attached patches to 
investigate the nature of the KATP channel in these mouse strains. A trace amount of ATP 
(1 μM) was added into the basal high K+ bath solution to decrease the level of channel 
rundown (12). Representative single KATP channel activities are shown in Figure 5A. In 
WT cells, KATP channels were highly active under the control condition with 1 μM ATP, 
and responded well to an increase of ATP to 100 μM in the bath solution. On the 
contrary, KATP channels in TG cardiomyocytes stayed poorly active even under the 
control condition (1 μM ATP). The calculated open probability at the control condition 
(NPc) showed that TG strains had significantly lower KATP channel activities (Figure 
5B). The amplitude of unitary current was measured at the control condition. In open 
cell-attached patches with pipette potential held at +40 mV, there was no significant 
difference in the amplitude of unitary current (in pA, WT: 3.42 ± 0.07, TGmt Line 105: 
3.33 ± 0.06, and TGWT Line 634: 3.13 ± 0.12, 5–6 cells in each strain), suggesting that 
conductance of sarcolemmal KATP channels was similar in these ventricular myocytes. 
Further, ATP sensitivity of the channel was analyzed. KATP channel activities at 
various ATP concentrations (1–1000 μM) was normalized to that with 1 μM ATP 
(Figure 5C). ATP inhibited the KATP channel activities in a concentration-dependent 
manner, and 1 mM ATP was enough to repress the KATP channel activities completely. 
Although there were significantly large differences between WT and TG strains in the 
open probabilities at the control condition (NPc) (Figure 5B), ATP-dependency of the 
channel inhibition was almost identical between the patches of WT and two TG strains 
(Figure 5C). There were no significant differences in IC50 value for ATP among the 
three groups (mean [95% confidence interval] (μM), WT: 26.8 [18.3–39.2], TGmt Line 
105: 16.5 [12.1–22.4], and TGWT Line 634: 12.3 [6.7–22.5], 5–6 cells in each group). 
Collectively, it was suggested that there were no significant differences between the 
cardiac KATP channels of TG and WT animals in the ATP sensitivity and single channel 
conductance; furthermore, electrophysiological analyses revealed that S422L variant of 
KCNJ8 was functionally almost identical to S422 wild type in the transgenic mouse 
hearts. 
 
 
 
 
4. Discussion 
Our KCNJ8 (Kir6.1) transgenic mice expressing S422L variant (TGmt) and 
S422 wild type (TGWT) exhibited atypical ECG patterns; however, there were no 
differences between the variant and wild-type transgenic animals in electrophysiological 
analyses. 
Mouse ECGs normally exhibit “J wave” as a notch after the QRS complex (14). 
Both TG mouse strains showed ECG abnormalities characterized by changes of the J-
ST segment. The ECG patterns were mostly divided into two patterns; namely 
“enlarged J wave pattern” and “J-ST segment depression pattern”, both of which were 
associated with marked QT prolongation. There might be a possibility that these 
changes derived from a non-specific consequence of protein expression under the 
control of the alpha-MHC promoter. There have been previous demonstrations that non-
specific overexpression of protein (e.g. GFP) in the heart leads to a gradual heart failure 
(15), and many K+ currents are down-regulated in such conditions (16). However, ECG 
abnormalities shown by our TG mouse strains are not the ones similar to other TG 
mouse strains (17,18). This fact supports that ECG abnormalities in our TG model are 
not the consequence of non-specific overexpression of protein in the heart.  
It was revealed that APD90 of TG ventricular cells was significantly longer than 
that of WT cells, explaining the QT prolongation in ECG of TG strains. Furthermore, 
the voltage-dependent K+ current (Ito, IK, IK1) densities were down-regulated in 
ventricular cells of both TG strains, which might be responsible for the APD 
prolongation and the resultant QT/QTc prolongation. Interestingly, similar phenomenon 
was reported in another study showing that marked decreases in Ito and IK1 densities 
were observed in cardiomyocytes of transgenic mice overexpressing voltage-dependent 
K+ channel α-subunit (KCNQ1-isoform) although the precise mechanisms remain 
unclarified (19).  
It has been reported that there are marked regional differences in the densities of 
voltage-dependent K+ channels in adult mouse ventricles, which may contribute to ECG 
waveform (20). Down-regulation of K+ currents with different degrees in various parts 
of TG mouse ventricles might produce atypical ECG changes although we did not 
investigate the regional differences in the K+ current densities in this study. 
The S422L mutation in the KCNJ8 gene was first described in association with 
ERS (4). In heterologous expression system using cultured cells, KATP channel 
assembled with S422L mutant Kir6.1 and SUR2A showed increased current density of 
KATP channel compared with that of Kir6.1 wild-type channel, and therefore the gain-of-
function mutation of Kir6.1 with the reduced sensitivity (~one-twentieth) to ATP has 
been lined up as a cause of JWS (5,6). Contrary to our expectations, the density of 
pinacidil-induced KATP current was lower in ventricular cells of both TG mouse strains 
compared with that observed in WT ventricular cells in this study. In addition, there was 
no significant difference in the density of pinacidil-induced KATP current between TGmt 
and TGWT ventricular cells. In our single channel patch-clamp experiments, the open 
probability of KATP channels was significantly lower in TGmt and TGWT ventricular 
cells in a control condition. Furthermore, the ATP sensitivity of the KATP channel in 
TGmt ventricular cells was almost same with that of the KATP channel in TGWT 
ventricular cells. The ATP sensitivity of the KATP channel in TGmt ventricular cells was 
not decreased in comparison with that of WT ventricular cells. Thus, the 
electrophysiological data obtained from TGmt and TGWT mice failed to support the 
Kir6.1 gain-of-function mutation hypothesis as a direct cause of JWS. 
It is still controversial whether the mutation directly associates with JWS. 
Cooper et al. reported that co-expression of Kir6.1-S422L variant with SUR1 in COS 
cells did not lead to a gain of KATP channel function, although another variant form, 
Kir6.1-C176S, found in a patient with Cantú syndrome, gave rise to enhanced KATP 
channel activity with reduced ATP sensitivity when co-expressed with SUR1 or SUR2A 
(21). In addition, it has been reported that Kir6.1-S422L allele was found at a higher 
frequency (~4%) in Ashkenazi Jewish cohort, and there was no evidence showing that 
they had a predisposition to lethal arrhythmias. Although the ECG recording from a 
parent who is heterozygote for the S422L mutation presented a subtle J-point elevation, 
the homozygote son demonstrated no significant ECG abnormalities (22). Therefore, it 
would be useful for further deliberative research to be carried out which ensures that the 
Kir6.1-S422L mutation is a direct cause of JWS.  
We previously reported that KATP channel function in cardiomyocytes was 
completely blunted in Kir6.2-null mice whereas the channel function was preserved in 
vascular smooth muscle cells (12,23). On the other hand, Kir6.1-null mice showed 
different phenotypes from Kir6.2-null mice; coronary vasospasm resulting in the sudden 
cardiac death like Prinzmetal angina (24). Therefore, it has been postulated the 
functional relevance of Kir6.2 in cardiac KATP channels, whereas Kir6.1 for vascular 
KATP channels (7). In this context, it is noteworthy that pinacidil-induced KATP current, 
as well as APD shortening, can be observed in ventricular cells of Kir6.1-null mice to a 
similar extent with WT mice (24). Therefore, it is unlikely that Kir6.1 is dominant in the 
sarcolemmal KATP channel function, at least in the mouse heart, although the role of 
Kir6.1 in cardiomyocytes remains unclear. In the present study, there was no significant 
difference in the amplitude of unitary KATP channel current in ventricular cells among 
WT, TGmt, and TGWT. It was reported that unitary conductance was decreased when 
KATP channel was constructed as Kir6.1 or Kir6.1–6.2 tandem co-expressed with 
SUR2A in a heterologous expression system (25). These findings also support the 
concept that Kir6.2 but not Kir6.1 plays an important role in the function of 
sarcolemmal KATP channel in the mouse heart. Furthermore, Kir6.1-S422L mutation 
could not affect sarcolemmal KATP channel function since we could not find any 
differences between TGmt and TGWT at single channel level. 
We analyzed the gene expression levels of Kir6.2, SUR1 and SUR2 in ventricular 
tissues of WT, TGmt and TGWT mice. The mRNA expression levels of Kir6.2 and 
SUR2 tended to be decreased in the TGmt and TGWT ventricles when compared with 
those in WT ventricle (data not shown). These findings may partly explain the 
decreased activity of Kir6.2-assembled KATP channel although the precise mechanism(s) 
remain unclarified.  
In conclusion, electrophysiological analyses of KCNJ8 transgenic mice did not 
substantiate the S422L mutation in KCNJ8 gene as a direct cause of JWS although 
atypical ECG changes were observed in these TG mice. 
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Figure Legends 
 
Figure 1. Representative surface ECG recorded from WT and TG mice 
A: Characteristic changes in the J-ST segment in Kir6.1 TG mice. Mouse ECG 
normally has a notch (J wave) after the QRS complex with the inverted T wave 
(enlarged view in the inset). The J-ST segment is the point where Kir6.1 TG mice 
represent characteristic changes, such as an enlarged J wave or J-ST segment 
depression. Enlarged J wave was defined when the ratio of J wave area to QRS area was 
greater than 0.25. J-ST segment depression was ECG change with J point depression 
more than 0.1mV. J-ST segment depression was the major form in Line 111 (TGmt) 
(92%) and Line 634 (TGWT) (95%), although 30% of Line 105 (TGmt) and 81% of 
Line 673 (TGWT) showed enlarged J wave rather than J-ST depression. No 
spontaneous interconversion between these patterns was observed in the subject. There 
were few mice in TG strains showing WT pattern. 
B: QT prolongation in TG mouse strains. QT and QTc interval, calculated using 
Mitchell’s formula (QTc = QT/(RR/100)½), were longer by about 60–100% in both TG 
strains compared with WT. Among the four TG lines, Line 673 showed shortest QT/QTc 
intervals. These strains showed sinus rhythm, and there were no significant differences 
in heart rate and PQ interval. N = 8–21 (mice) in each group. Data are presented as 
mean ± SEM. * p < 0.01 vs. WT, # p < 0.01 vs. Line 673, respectively. 
 
Figure 2. APD prolongation in ventricular cells of Kir6.1 TG mouse strains 
A: Action potentials recorded from cardiomyocytes of WT and TG strains at an interval 
of 5 s. APD (action potential duration) was markedly prolonged in TGmt (Line 105) and 
TGWT (Line 673) strains. 
B: APD90 (APD at the 90% repolarization level) measured from WT and TG ventricular 
cells. APD90 was about 100–200% longer in TG ventricular cells compared with WT. 
There were no significant differences between TGmt and TGWT in APD90. No 
difference was observed in the resting membrane potential and the phase-0 amplitude 
among ventricular cells of all experimental groups. N = 11–30 (cells) in each group. 
Data are expressed as mean ± SEM.      * p < 0.01 vs. WT 
 
Figure 3. Voltage-dependent K+ currents in WT and TG ventricular cells 
A: Representative traces of Ito and IK1 in ventricular myocytes from WT and TG mice. 
The transient outward current (Ito) was measured by delivering 300-ms depolarizing 
pulses from a holding potential of −70 mV at 0.1 Hz, following a 20-ms prepulse to −40 
mV to inactivate Na+ current, in a solution containing 2 mM CoCl2. The delayed 
rectifier K+ current (IK) and the inward rectifier K+ current (IK1) were obtained by 
delivering stepwise depolarization pulses (from −30 mV to +40 mV) and stepwise 
hyperpolarization pulses (from −50 mV to − 100 mV) from a holding potential of −40 
mV, respectively. The amplitude of these currents was measured at the end of test 
pulses. Pulse protocols for these voltage-clamp experiments are shown on the right side. 
Cardiomyocytes from TGmt and TGWT had lower peaks for Ito than that from WT. 
Furthermore, IK1 in TG strains were as well smaller than that in WT. 
B: Summarized data of voltage-dependent K+ current densities in WT and TG 
ventricular cells. Current densities are summarized for Ito at +50 mV, IK at +40 mV, and 
IK1 at −60 mV. Overall, TG ventricular cells exhibited less K+ current densities than that 
from WT cells. Although there were no significant differences in the Ito, IK, and IK1 
densities among the four TG lines, Line 673 TG showed comparatively large current 
density, especially in Ito and IK1. Therefore, it may be reasonable that Line 673 (TGWT) 
has shorter APD and QT/QTc intervals compared with other TG lines. N = 5–21 (cells) 
in each group. Data are expressed as mean ± SEM. * p < 0.05 vs. WT 
 
Figure 4. Pinacidil-induced KATP current in WT and TG ventricular cells 
A: Representative current traces recorded from ventricular cells from TG strains and 
WT. 
The quasi-steady-state membrane current was recorded using the ramp pulse protocol 
(Inset) at an interval of 5 s. The membrane potential was held at −40 mV and 
depolarized to +50 mV in 300 ms. It was then repolarized or hyperpolarized to −100mV 
in 500 ms, during which time the membrane current was automatically plotted against 
the membrane potential. Although pinacidil (100 μM) definitely induced glibenclamide 
(10 μM)-sensitive KATP current in all cases, KATP currents observed in TGmt and TGWT 
cells were smaller than that in WT cells. Pin: pinacidil; Glb: glibenclamide 
B: Pinacidil (100 μM)-induced KATP current densities at 0 mV in ventricular myocytes. 
The KATP current densities in TGmt and TGWT ventricular myocytes were lower by 
about 40–60% than those from WT cells. There was no significant difference between 
TG strains (TGmt and TGWT). N = 5–13 (cells) in each group. Data are expressed as 
mean ± SEM.  * p < 0.01 vs. WT 
C: Concentration response curves for pinacidil-induced KATP current in ventricular cells 
from WT and TG strains. Pinacidil-induced KATP current densities in TG ventricular 
myocytes were smaller than that from WT cells. In our experimental settings, each cell 
was exposed to one dose of pinacidil to minimize the effect from the channel rundown. 
N = 5–18 (cells) in each group. Data are expressed as mean ± SEM. 
 
Figure 5. Single KATP channel recordings from open cell-attached patches in 
ventricular cells of WT and TG strains 
A: Representative traces of single KATP channel currents.  A trace amount of ATP (1 
μM) was added into the basal high K+ bath solution to decrease the channel rundown. 
KATP channels in WT ventricular myocyte were highly active under the control 
condition (with ATP 1 μM) and responded well to an increase of ATP to 100 μM in the 
bath solution. In contrast, KATP channels in TG ventricular myocytes are less active even 
in the control condition; however, they well responded to an increase in cytosolic ATP. 
Upward deflections depict the outward KATP currents from the glass electrode. 
B: Open probability (NPc) of the KATP channel at the control condition (1 μM ATP). 
There was no difference between TGmt and TGWT in NPc, although it was 
significantly higher in WT than Kir6.1 TG strains. N = 5–6 (cells) in each group. Data 
are expressed as mean ± SEM. * p < 0.01 vs. WT 
C: Relative open probability (NP/NPc) with varying cytosolic ATP concentrations. 
Single KATP channel currents, observed in Kir6.1 TG as well as WT, were all sensitive to 
ATP to a similar extent. There was no significant difference in IC50 value for ATP 
among the three groups. N = 5–6 (cells) in each group. Data are expressed as mean ± 
SEM. 
 
 
 
 
 
Table 1. Primer sets used for PCR
Primer Name Sequence (5' - 3')
Kir6.1HumRat-S422L.For AAACCAGAATACTCTAGAATCATGAGGGCAGGAT
Kir6.1HumRat-S422L.Rev ATGATTCTAGAGTATTCTGGTTTCCTTCTGGAGT
Kir6.1rRT.For AAGGCATCACGGAGAAGAGT
Kir6.1rRT.Rev GAGAAACGCAGAAGTGAATGAC
Kir6.2mRT.For AAGGCCAAGCCCAAGTTTA
Kir6.2mRT.Rev CCACCACTCTACATACCATACTTCAC
SUR1mRTnew.For CTTCAGCGGCACCATCAGA
SUR1mRTnew.Rev TCCAGAGCCTCCCAGAGTGT
SUR2mRT.For GGAGTGTGATACTGGTCCAA
SUR2mRT.Rev ACCAGGTCTGCAGTCAGAAT
RPL4.MouseNew.For GCCAAGACTATGCGCAGGAAT
RPL4.MouseNew.Rev GTAGCTGCTGCTTCCAGCTT
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